FDA Inspection
Grifols d.b.a. Biomat USA, Inc.Grifols d.b.a. Biomat USA, Inc. – FDA Inspection, Mar 23, 2012
Record Details
This FDA Inspection record concerns Grifols d.b.a. Biomat USA, Inc., with an inspection on March 23, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 23, 2012
- Product Type
- Biologics
View Company Profile
ID · 3c25094b-6e94-4084-9971-64768b292f34
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 774404
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Grifols d.b.a. Biomat USA, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 29, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 14, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Grifols d.b.a. Biomat USA, Inc.
- FDA Inspection 1210052 - 2023-06-29
- FDA Inspection 1020657 - 2017-07-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.